openPR Logo
Press release

Sarcoidosis Drug Market Growth, Share, Size and Forecasts 2019-2026: With Relief therapeutics holding SA, Firststring research, Bellus health, Araim Pharmaceuticals, Inc., Merck & Co., Inc, Novartis AG

07-08-2019 03:23 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Sarcoidosis Drug Market

Sarcoidosis Drug Market

Global sarcoidosis drug market is rising gradually registering a CAGR of 4.1% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing awareness and concerns regarding the health of patients, growing prevalence of sarcoidosis and number of research undertaking and funding to control the rising prevalence of this disease, changing lifestyle, advancements in the health care industry and rising per capita income in emerging markets.

Get Free Sample Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-sarcoidosis-drug-market

Market Definition: Global Sarcoidosis Drug Market

Sarcoidosis is a rare inflammatory disease that causes small granulomas in the multiple organs of the body mainly lungs, lymph nodes and skin where the nodules are filled with inflammatory cells. The person with sarcoidosis initially experiences fatigue, swollen lymph nodes, weight loss, pain and swelling in joints, reddish bumps or patches on the skin or under the skin. According to the America’s population based study in the year 2010-2013, around 29,372 adult patients with sarcoidosis were reported. 14,700 of these were 55 years of age at the time of diagnosis. For African Americans the incidence rate is higher, 17.8 and 141.4 per 100,000 respectively, for Asians (3.2 and 18.9), white peoples (8.1 and 49.8) OR Hispanics (4.3 and 21.7). The incidence rate of having sarcoidosis in women is two times higher than men. Afro-American women have the highest sarcoidosis prevalence of 178.5.

Key Market Players: Global Sarcoidosis Drug Market

Some of the major players operating in global sarcoidosis drug market are

• Relief therapeutics holding SA,
• Firststring research,
• Bellus health,
• Araim Pharmaceuticals, Inc.,
• Merck & Co., Inc,
• Novartis AG,
• PharmaIN, Corp.,
• Adaptimmune Therapeutics plc.,
• Epizyme, Inc.,
• Advenchen Laboratories, LLC,
• Fresenius Umwelttechnik GmbH,
• Horizon Therapeutics plc,
• Johnson & Johnson Services, Inc,
• Pfizer Inc,
• Mallinckrodt LLC are some key market players.

Key Developments in the Market:

• In December 2018, aTyr Pharma, Inc. announced that ATYR1923 drug which is designed to evaluate safety, tolerability and immunogenicity is under Phase 1b/2a of clinical trial for the treatment of pulmonary sarcoidosis and improving care for sarcoidosis patients.

• In July 2016, Abbvie Inc. received approval for the drug Humira (adalimumab) which is efficient in minimizing the symptoms of sarcoidosis. Humaira is injected subcutaneously and it can be used to treat patients who cannot be treated with other sarcoidosis treatments

Competitive Analysis: Global Sarcoidosis Drug Market

Global sarcoidosis drug market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of sarcoidosis market for global Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Market Drivers

• The increasing awareness and concerns regarding the health of patients is driving the market growth

• Growing prevalence of sarcoidosis is acting as a catalyst for the market growth

• Number of research undertaking and funding to control the rising prevalence of this disease is encouraging its market growth

• Advancements in the health care industry and rising per capita income in emerging markets is accelerating the market growth

Market Restraints

• Large number of side effects of available drugs is hindering the market growth

• Effective treatment is either unavailable or unaffordable is hampering the market growth

• Lack of awareness among the patient and physician about sarcoidosis is restraining the market growth

For More Details In-Depth Inquiry @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-sarcoidosis-drug-market

Segmentation: Global Sarcoidosis Drug Market

By Type

• Pulmonary sarcoidosis
• Ocular sarcoidosis
• Neurosarcoidosis
• Cardiac sarcoidosis
• Musculoskeletal sarcoidosis
• Cutaneous sarcoidosis
• Renal sarcoidosis
• Hepatic sarcoidosis
• Sarcoidosis of the spleen and bone marrow

By Mechanism of Action Type

• Corticosteroid
• Immunosuppressants
• Antimalarial
• Tumor necrosis factor-alpha (TNF-alpha) inhibitors

By Drug Type

• Corticotropin
• Chloroquine
• Dexamethasone
• Colchicine
• Prednisoe
• Methotrexate
• Hydroxychloroquine
• Azathioprine
• Deltason

Stages Type

• Stage 0 (no pulmonary sarcoidosis): no sign of granulomas in the lungs or lymph nodes
• Stage 1 (lymphadenopathy): granulomas present in the lymph nodes only
• Stage 2 (lymphadenopathy and pulmonary infiltrates): granulomas present in both the lymph nodes and lung
• Stage 3 (pulmonary infiltrates): granulomas present in the lungs only
• Stage 4 (pulmonary fibrosis): scarring of the lung tissue and permanent damage

By Route of Administration

• Oral
• Inhaled
• Intravenous
• Subcutaneous

By End users

• Hospitals
• Homecare
• Specialty Clinics
• Others

By Geography

• North America

• South America

• Europe

• Asia-Pacific

• Middle East & Africa

Reasons to Purchase this Report

• Current and future of global sarcoidosis market outlook in the developed and emerging markets

• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

• Regions/Countries that are expected to witness the fastest growth rates during the forecast period

• The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

• All segmentation provided above in this report is represented at country level

• All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Buy Full Report Now @ https://databridgemarketresearch.com/checkout/buy/enterprise/global-sarcoidosis-drug-market

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sarcoidosis Drug Market Growth, Share, Size and Forecasts 2019-2026: With Relief therapeutics holding SA, Firststring research, Bellus health, Araim Pharmaceuticals, Inc., Merck & Co., Inc, Novartis AG here

News-ID: 1799054 • Views:

More Releases from Data Bridge Market Research

Water Treatment System Market: Sustaining the Future of Clean Water
Water Treatment System Market: Sustaining the Future of Clean Water
Introduction Understanding Water Treatment Systems Water treatment systems are designed to purify and disinfect water for various uses-drinking, industrial processes, irrigation, and wastewater reuse. These systems eliminate contaminants such as bacteria, viruses, heavy metals, chemicals, and particulates, making water safe and sustainable for consumption and use. Importance in Global Sustainability Clean water is essential to life and industrial progress. With growing water demand and pollution, water treatment systems are now critical infrastructure across the
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal

All 5 Releases


More Releases for Sarcoidosis

Sarcoidosis Market Massive Growth opportunity Ahead
Introduction Sarcoidosis is a rare, multisystem inflammatory disease characterized by the formation of granulomas in organs such as the lungs, skin, eyes, and lymph nodes. Although its exact cause remains unknown, it is believed to be linked to immune system overactivation, genetic predisposition, and environmental triggers. While many cases resolve spontaneously, chronic sarcoidosis can cause severe complications, particularly in pulmonary and cardiac systems. The global sarcoidosis market is gaining attention as healthcare
Pulmonary Sarcoidosis Market Dynamics Indicate Upward Trajectory Through 2032, R …
The Pulmonary Sarcoidosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Pulmonary Sarcoidosis pipeline products will significantly revolutionize the Pulmonary Sarcoidosis market dynamics. DelveInsight's "Pulmonary Sarcoidosis Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Pulmonary Sarcoidosis, historical and forecasted epidemiology as well as the Pulmonary Sarcoidosis market trends in the United
Sarcoidosis Market Set to Eyewitness Substantial Growth by 2024-2031
The Latest research report on the Sarcoidosis Market 2024 provides a comprehensive analysis of the current market landscape, with forecasts extending to 2031. This study combines qualitative and quantitative insights to highlight significant market developments, challenges, competitive dynamics, and potential opportunities and trends shaping the Sarcoidosis Market. The report covers market size, recent trends, growth projections, market share, and development status. Additionally, it examines government policies, market dynamics, cost structures,
Pulmonary Sarcoidosis Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Pulmonary Sarcoidosis Pipeline Insight 2024" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Pulmonary Sarcoidosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Discover the latest drugs and treatment options in the Pulmonary
Pulmonary Sarcoidosis Pipeline Insights, Clinical Trials, Emerging Drugs and Com …
DelveInsight's, "Pulmonary Sarcoidosis Pipeline Insight 2024" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Pulmonary Sarcoidosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Discover the latest drugs and treatment options in the Pulmonary Sarcoidosis
Sarcoidosis Drugs Market Size, Future Growth, Segments Forecast 2022-2028
Precision Business Insights published a research report on " Sarcoidosis Drug Market: By Product Type (Tumor Necrosis Factor Alpha (TNF-α) Inhibitors, Corticosteroids, Immunosuppressant Drugs, Others), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography - Global/Region/Country Forecast to 2028" Sarcoidosis is an inflammatory disorder characterised by the growth of small collections of inflammatory cells. It can affect any organ in the body,